Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Cataract, Cornea / Ocular Surface

Doubling Down on Virtual Surgery

sponsored by Optimo Medical

As biomechanical expertise continues to grow in ophthalmology, it has become clear that no two eyes are the same – not even those of the same individual. But with the advent of digital technologies across healthcare, including advances in artificial intelligence and the digital twin, whole new levels of personalization are now achievable in ophthalmic surgery. Harald P. Studer, CEO of Optimo Medical AG, tells us how combining these advances with sophisticated software solutions is enabling patient-specific eye surgery that ensures optimal outcomes for patients.

How are advances in digital technologies shaping the landscape of ophthalmology? 

Standard-of-care cataract and corneal surgery relies on high-tech diagnostic and therapeutic devices, yet the planning of treatments is often still done with old-fashioned, statistically based, and non-personalized methods. Because it becomes increasingly apparent that every eye is unique, personalization emerges as the key to successful cataract surgery. In silico digital models, such as our OptimeyesTM software, are enabling clinicians to more accurately predict the outcomes of surgical procedures and minimize risk for the patient.

How is Optimo Medical AG using these advanced tools and what benefits can they offer to ophthalmologists?

At Optimo Medical AG, we are building on current digital twin technology, combining our extensive knowledge of corneal biomechanics with a wealth of expertise in mathematics and computational modeling to create OptimeyesTM. This software offers surgeons a safe, precise, and low-cost method for patient-specific surgery planning, replacing the traditional statistical guesswork of nomograms. The state-of-the-art technology is able to produce a virtual clone of the anterior segment of the patient’s eye, meaning a surgeon can perform a “dry-run” to establish the optimal surgery parameters. First, a patient's individual anterior segment tomography measurements are imported into the software, based on biomechanical simulations. Then, the surgical parameters for femto-laser arcuate keratotomy are modeled and optimized, including values for optical zone, incision length, incision depth, and orientation.

Patients are often left with treatable astigmatism after cataract surgery; by using the software for preoperative arcuate keratotomy planning, surgeons can ensure any residual astigmatism from cataract surgery is minimized – this is a key benefit.

How do you see technologies such as yours developing in the near and longer-term future?

With both the FDA and the European Council recommending the use of virtual surgery to create digital simulations of patient outcomes and modernize the evaluation of patient benefit and risk, it is clear that digital technologies, such as OptimeyesTM,will significantly advance the field of ophthalmology and healthcare as a whole. The ability to conduct in silico patient-specific surgery planning will enable truly personalized procedures that will drastically improve refractive outcomes for patients. We believe artificial intelligence, in combination with digital twin technologies, will become the standard of care in surgery planning across ophthalmology and will help improve surgical outcomes exponentially.

OptimeyesTM is CE marked and available for sale in Europe only.

Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Ophthalmologist site. It’s FREE!

Login

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

About the Author

Harald P. Studer

CEO of Optimo Medical AG

Newsletter

Send me the latest from The Ophthalmologist.

Sign up now

Most Popular

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register